There is great power in comparing several human tissue types across the continuum of malignancy to identify commonalities in their response to stress and their potential to generate genetic diversity and activate evolutionary forces. In this application, all four Projects will use the human cells described in this Shared Resource. The two tissue types we have chosen for our initial studies center on two ofthe most common tumor types in humans, breast and prostate tissues. Each is hormonally driven and represents the most important clinical problems in both their early and late stages of malignant transformation. Currently the cell of origin for various human tumors is unknown. In breast tumors, luminal cell markers are often expressed and investigators have long hypothesized that the majority oftumor cells originate from the luminal population. For several decades, and more recently with in depth molecular analysis, many stem cell characteristics have been detected in tumor cells and, correspondingly, investigators have postulated that adult stem cells represent the cell of tumor origin. Our Resource wili provide our Investigators with each relevant population of purified cells to determine if differential responses to stress and activation of evolutionary forces distinguish the different populations. Cells will be evaluated after growth in both 2-D and 3-D conditions.

Public Health Relevance

This Resource will provide our Investigators with each relevant population of purified cells to determine if differential responses to stress and activation of evolutionary forces distinguish the different populations. Cells will be evaluated after growth in both 2-D and 3-D conditions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA143803-03
Application #
8323589
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2011-08-01
Budget End
2012-07-31
Support Year
3
Fiscal Year
2011
Total Cost
$173,622
Indirect Cost
Name
Princeton University
Department
Type
DUNS #
002484665
City
Princeton
State
NJ
Country
United States
Zip Code
08544
van der Toom, Emma E; Axelrod, Haley D; de la Rosette, Jean J et al. (2018) Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies. Nat Rev Urol :
Valkenburg, Kenneth C; de Groot, Amber E; Pienta, Kenneth J (2018) Targeting the tumour stroma to improve cancer therapy. Nat Rev Clin Oncol 15:366-381
Chalfin, Heather J; Glavaris, Stephanie A; Malihi, Paymaneh D et al. (2018) Prostate Cancer Disseminated Tumor Cells are Rarely Detected in the Bone Marrow of Patients with Localized Disease Undergoing Radical Prostatectomy across Multiple Rare Cell Detection Platforms. J Urol 199:1494-1501
Chalfin, Heather J; Kates, Max; van der Toom, Emma E et al. (2018) Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method. Urology 115:82-86
de Groot, Amber E; Pienta, Kenneth J (2018) Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages. Oncotarget 9:20908-20927
Wu, Amy; Liao, David; Kirilin, Vlamimir et al. (2018) Cancer dormancy and criticality from a game theory perspective. Cancer Converg 2:1
Maley, Carlo C; Aktipis, Athena; Graham, Trevor A et al. (2017) Classifying the evolutionary and ecological features of neoplasms. Nat Rev Cancer 17:605-619
Piotrowski-Daspit, Alexandra S; Simi, Allison K; Pang, Mei-Fong et al. (2017) A 3D Culture Model to Study How Fluid Pressure and Flow Affect the Behavior of Aggregates of Epithelial Cells. Methods Mol Biol 1501:245-257
Parsana, Princy; Amend, Sarah R; Hernandez, James et al. (2017) Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration. BMC Cancer 17:447
Decker, A M; Cackowski, F C; Jung, Y et al. (2017) Biochemical Changes in the Niche Following Tumor Cell Invasion. J Cell Biochem 118:1956-1964

Showing the most recent 10 out of 105 publications